Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,695 | -78,847 | -56,703 | -30,754 | -134,850 |
| Depreciation Amortization | -256 | -293 | -299 | -248 | -3,520 |
| Accounts payable and accrued liabilities | 421 | 2,090 | 409 | -556 | -4,024 |
| Other Working Capital | 336 | -403 | -2,527 | 645 | -12,430 |
| Other Operating Activity | 17,052 | 12,291 | 11,051 | 6,250 | 32,912 |
| Operating Cash Flow | $-84,142 | $-65,162 | $-48,069 | $-24,663 | $-121,912 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -212 | -163 | -107 | -60 | -447 |
| Purchase Of Investment | -51,593 | -45,619 | -41,177 | -15,775 | -107,406 |
| Sale Of Investment | 134,391 | 117,135 | 91,245 | 43,480 | 194,109 |
| Investing Cash Flow | $82,586 | $71,353 | $49,961 | $27,645 | $86,256 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -435 | N/A | N/A | N/A | N/A |
| Debt Repayment | -929 | -704 | -544 | -307 | -827 |
| Common Stock Issued | 38 | 16 | 15 | N/A | 1,983 |
| Other Financing Activity | 1,688 | 372 | 372 | 372 | 29,661 |
| Financing Cash Flow | $362 | $-316 | $-157 | $65 | $30,817 |
| Beginning Cash Position | 17,633 | 17,633 | 17,633 | 17,633 | 22,472 |
| End Cash Position | 16,439 | 23,508 | 19,368 | 20,680 | 17,633 |
| Net Cash Flow | $-1,194 | $5,875 | $1,735 | $3,047 | $-4,839 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,142 | -65,162 | -48,069 | -24,663 | -121,912 |
| Capital Expenditure | -212 | -163 | -107 | -60 | -447 |
| Free Cash Flow | -84,354 | -65,325 | -48,176 | -24,723 | -122,359 |